Naloxone; possession and administration, employee or person acting on behalf of a public place. (HB908)
Introduced By
Del. Cliff Hayes (D-Chesapeake) with support from co-patron Del. Wendy Gooditis (D-Clarke)
Progress
✓ |
Introduced |
✓ |
Passed Committee |
✓ |
Passed House |
✓ |
Passed Senate |
✓ |
Signed by Governor |
☐ |
Became Law |
Description
Naloxone; possession and administration; employee or person acting on behalf of a public place. Authorizes an employee or other person acting on behalf of a public place, as defined in the bill, who has completed a training program on the administration of naloxone or other opioid antagonist to possess and administer naloxone or other opioid antagonist, other than naloxone in an injectable formulation with a hypodermic needle or syringe, in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health. The bill also provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill provides immunity from civil liability for a person who, in good faith, administers naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, unless such act or omission was the result of gross negligence or willful and wanton misconduct. This bill incorporates HB 650, HB 1465, and HB 1466. Read the Bill »
Outcome
History
Date | Action |
---|---|
01/07/2020 | Committee |
01/07/2020 | Prefiled and ordered printed; offered 01/08/20 20104833D |
01/07/2020 | Referred to Committee on Health, Welfare and Institutions |
01/16/2020 | Impact statement from DPB (HB908) |
01/20/2020 | Assigned HWI sub: Health Professions |
01/30/2020 | Subcommittee recommends reporting with substitute (6-Y 0-N) |
02/04/2020 | Committee substitute printed 20107306D-H1 |
02/04/2020 | Incorporates HB 1465 (Gooditis) |
02/04/2020 | Incorporates HB1466 (Gooditis) |
02/04/2020 | Incorporates HB650 (Hope) |
02/04/2020 | Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) (see vote tally) |
02/05/2020 | Read first time |
02/06/2020 | Read second time |
02/06/2020 | Committee substitute agreed to 20107306D-H1 |
02/06/2020 | Engrossed by House - committee substitute HB908H1 |
02/07/2020 | Read third time and passed House BLOCK VOTE (100-Y 0-N) |
02/07/2020 | VOTE: Block Vote Passage (100-Y 0-N) (see vote tally) |
02/10/2020 | Impact statement from DPB (HB908H1) |
02/10/2020 | Constitutional reading dispensed |
02/10/2020 | Referred to Committee on Education and Health |
02/27/2020 | Reported from Education and Health (14-Y 0-N) (see vote tally) |
02/28/2020 | Constitutional reading dispensed (37-Y 0-N) (see vote tally) |
03/02/2020 | Read third time |
03/02/2020 | Passed Senate (40-Y 0-N) (see vote tally) |
03/05/2020 | Enrolled |
03/05/2020 | Bill text as passed House and Senate (HB908ER) |
03/05/2020 | Impact statement from DPB (HB908ER) |
03/06/2020 | Signed by Speaker |
03/06/2020 | Signed by President |
03/12/2020 | Enrolled Bill communicated to Governor on March 12, 2020 |
03/12/2020 | G Governor's Action Deadline 11:59 p.m., April 11, 2020 |
04/09/2020 | G Approved by Governor-Chapter 924 (effective 7/1/20) |
04/09/2020 | G Acts of Assembly Chapter text (CHAP0924) |